Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North American …
Tag: Cronos Group
Cronos Group Raises $10 Million Selling Shares at $2.25
Cronos Announces Private Placement of Common Shares TORONTO, Sept. 14, 2017 /CNW/ – Cronos Group Inc. (“Cronos” or the “Company”) (TSX Venture: MJN) (OTC – Nasdaq International Designation: …
Cronos Israel to Build Cannabis Production Facility Initially Targeting 5000 KG Annual Production
Cronos Establishes International Low Cost Production in Israel TORONTO, Sept. 6, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is pleased to announce th…
Cronos Group CEO Reveals Strategy in Exclusive Interview
The Cronos Group (TSXV: MJN) (OTC: PRMCF), which owns Canadian licensed producers Peace Naturals and In the Zone and has several other investments among LPs, had a management change in …
Romspen to Lend up to $40MM to Cronos Group
Cronos Group Secures $40M in Debt for Domestic Capacity Expansion TORONTO, Aug. 24, 2017 /CNW/ – Cronos Group Inc. (TSXV:MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is announcing today tha…
Canadian Cannabis Stocks Bounce Back
After a big 2nd half of 2016 and some strength in early 2017, Canadian LPs were under heavy pressure from April through June following a glut of supply (new publicly-trading …
Cannabis Extracts: The Next Canadian Oil Boom
Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015. While these products are …
Peace Naturals to Build 286K Sq. Ft. Indoor Cannabis Facility
Cronos Breaks Ground on World’s Largest Purpose-Built Indoor Cannabis Facility TORONTO, May 23, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is p…
Cannabis Now a Global Investment Opportunity
Readers of New Cannabis Ventures likely recall how we alerted to the huge opportunities in Canada last June, and the Canadian market continues to evolve as a leader in the global …
Canada Demands Mandatory Pesticide Testing of All Cannabis After Contaminations at Peace Naturals and Hydropothecary
Statement from Health Canada on Mandatory Testing of Medical Cannabis for Unauthorized Pesticides OTTAWA, May 5, 2017 /CNW/ – Health Canada is committed to protecting the health and safety of …
Canadian Medical Cannabis Patient Population Soars 227%
While Health Canada, which provided an update on April 24th, continues to get the official data out to the public very slowly, the patient enrollment growth in the ACMPR program …
How to Invest in Canadian Cannabis Stocks
With Canada set to make history this week by tabling legislation to make the nation the first G-7 country to legalize cannabis for adult use, many investors are focusing on …
PI Financial Analyst Projects $4.6 Billion Canadian Cannabis Sales in 2019
Exclusive Interview with Jason Zandberg of PI Financial With Canada’s Liberal Party prepared to table legislation to legalize cannabis for adult use next week, we checked in with Jason Zandberg, …
Horizons Medical Marijuana ETF to Debut April 5th
Let’s face it, when it comes to cannabis stocks, Canada continues to crush the United States, where federal illegality makes it more difficult to operate and to raise capital. While …
Cronos Group Ups Investment in Whistler Medical Marijuana
Cronos Re-Invests in Whistler as Part of Transformative Expansion TORONTO, March 9, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos Group” or the “Company”) owns a 21.5% …
10 Canadian Cannabis LPs Heat Up Ahead of Key Legislation Introduction
After a boom in the stock prices of Canadian licensed producers (LPs) in 2016 that left the average stock up more than 355%, the sector is performing very well so …
PharmaCan Capital to Sell 6.7mm Shares at $2.25
PharmaCan Capital Announces $15 Million Bought Deal TORONTO, ONTARIO–(Marketwired – Feb. 14, 2017) – PharmaCan Capital Corp., doing business as Cronos Group (TSXV: MJN) (OTC: PRMCF) (“Cronos”…
Health Canada to Conduct Random Cannabis Testing for Pesticides
Statement from Health Canada on the Testing of Cannabis for Medical Purposes for Unauthorized Pest Control Products OTTAWA, Feb. 7, 2017 /CNW/ – Recently, two licensed producers of cannabis for …
How Canadian Cannabis Companies are Positioning for Germany’s New MMJ Program
Last week, James West of the Midas Letter published interviews of four CEOs of publicly-traded Canadian licensed producers, including Vic Neufeld of Aphria (TSXV: APH) (OTC: APHQF), Brent Zettl of CanniMed …
Leading Cannabis Companies to Present to NYC Institutional Investors
Investment Bank Cowen and Company, which initiated coverage on the cannabis industry in September, is hosting a gathering of institutional investors in New York City on January 12th. Several public …
Why Cannabis Investors Prefer Canada
Perhaps the biggest story of 2016 in the cannabis capital markets was the surge in prices and the amount of capital raised for the cannabis industry in Canada during the …
Canada Moves Closer to Cannabis Legalization with Task Force Report Publication
Canada’s Task Force on Cannabis Legalization and Regulation published its long-awaited report today. The report, delivered to Jody Wilson-Raybould, Minister of Justice and Attorney General of Canada, Jane Philpott,…
Canada to Cut Cannabis Reimbursement for Veterans While Now Covering Oils
Minister Hehr announces a new reimbursement policy for Cannabis for Medical Purposes VANCOUVER, Nov. 22, 2016 /CNW/ – The Honourable Kent Hehr, Minister of Veterans Affairs and Associate Minister of National …
PharmaCan Capital Now Cronos Group, Announces Key Hires
PharmaCan Announces Corporate Rebranding to Become Cronos Group TORONTO, ON–(Marketwired – October 06, 2016) – PharmaCan Capital (TSXV: MJN) (“the Company”) today announced a corporate rebra…
